Chemoinformaics analysis of Chrysin-7-Beta-D-Glucopyranoside
| Molecular Weight | 416.382 | nRot | 4 |
| Heavy Atom Molecular Weight | 396.222 | nRig | 24 |
| Exact Molecular Weight | 416.111 | nRing | 4 |
| Solubility: LogS | -3.734 | nHRing | 2 |
| Solubility: LogP | 2.127 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 55.6239 |
| nHD | 5 | BPOL | 26.1401 |
| QED | 0.406 |
| Synth | 3.694 |
| Natural Product Likeliness | 1.83 |
| NR-PPAR-gamma | 0.476 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.977 |
| HIA | 0.47 |
| CACO-2 | -5.675 |
| MDCK | 0.0000106 |
| BBB | 0.061 |
| PPB | 0.886224 |
| VDSS | 0.9 |
| FU | 0.0844891 |
| CYP1A2-inh | 0.521 |
| CYP1A2-sub | 0.058 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.084 |
| CYP2c9-sub | 0.56 |
| CYP2d6-inh | 0.138 |
| CYP2d6-sub | 0.187 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.044 |
| CL | 3.066 |
| T12 | 0.509 |
| hERG | 0.112 |
| Ames | 0.747 |
| ROA | 0.027 |
| SkinSen | 0.832 |
| Carcinogencity | 0.66 |
| EI | 0.207 |
| Respiratory | 0.066 |
| NR-Aromatase | 0.858 |
| Antiviral | Yes |
| Prediction | 0.853718 |